Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

353 projects found matching your search criteria :

  1. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  2. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  3. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  4. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  5. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  6. Molecular factors and pathomechanism of cancer-associated cachexia.

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Marcin Tomasz Skrzypski

    Gdański Uniwersytet Medyczny

  7. ERβ-mediated autophagy in colorectal cancer and its impact on carcinogenesis

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Julia Maria Lipowicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  8. Profiling of the stroma by spatial transcriptomics in aid of prognostication in FGFR2-mediated luminal breast cancer

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Julia Maria Sołek-Siejka

    Uniwersytet Medyczny w Łodzi

  9. Cellular effects in the tumor microenvironment and the potential for targeted delivery of molecules associated with the ...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: prof. Magdalena Maria Staniszewska

    Katolicki Uniwersytet Lubelski Jana Pawła II

  10. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Katarzyna Anna Malarz

    Politechnika Śląska

  11. Neutrophil-targeted immune response as an effective approach in immunotherapyof gastrointestinal cancers

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Damian Jacenik

    Uniwersytet Łódzki

  12. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  13. Proteomic predictors of metastasis in colorectal cancer – a validation study

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Anna Wojakowska

    Instytut Chemii Bioorganicznej PAN

  14. The Prognostic Utility of Circulating Tumor Cells (CTCs) Derived from the Portal Vein in Operable Colorectal Cancer Pati...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Claudia Dompé

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  15. The role of gratitude induced with a multi-component intervention in improving mental health outcomes of breast cancer p...

    Call: SONATINA 8 , Panel: HS6

    Principal investigator: dr Joanna Tomczyk

    Uniwersytet im. Adama Mickiewicza w Poznaniu

  16. Profiling of the phageome in relation to clinical outcomes in patients undergoing radical cystectomy and urinary diversi...

    Call: SONATINA 8 , Panel: NZ6

    Principal investigator: dr Katarzyna Anna Gembara

    Wojewódzki Szpital Specjalistyczny we Wrocławiu. Ośrodek Badawczo-Rozwojowy

  17. Cellular senescence as a new mechanism in development and progression of head and neck cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: prof. Michał Mateusz Masternak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  18. Defining the transcriptional and epigenetic state of tumor cells with increased plasticity and the epithelial-endothelia...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Kobielak

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  19. In search for DNA methylation aberrations associated with susceptibility to ovarian cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Malwina Magdalena Suszyńska

    Instytut Chemii Bioorganicznej PAN

  20. To be or not to be modified: the role of single m6A sites of long noncoding RNAs in breast cancer

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Elżbieta Wanowska

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  21. The role of oxidative stress, inflammation, disorders of purine metabolism, urea cycle and angiogenesis at the molecular...

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Paulina Wigner-Jeziorska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  22. Protease-induced neutrophilic networks in cancer development.

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Danuta Teresa Bryzek

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  23. Analysis of a mechanism, mediators and sequence of events in the context of an assessment of stimulatory effect of senes...

    Call: OPUS 2 , Panel: NZ3

    Principal investigator: dr hab. Krzysztof Stefan Książek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  24. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  25. Novel aspects of the mechanisms of vascular toxicity of tyrosine kinase inhibitors: studies on their proinflammatory act...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Tomasz Krzysztof Prajsnar

    Uniwersytet Jagielloński, Wydział Biologii

  26. Can extracts from Epilobium sp. inhibit proliferation of prostate cell LNCaP by influencing the activity of histone acet...

    Call: SONATA 1 , Panel: NZ4

    Principal investigator: dr hab. Anna Karolina Kiss

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  27. Vascular dysfunction after breast cancer neoadjuvant chemotherapy.The significance of menopausal status and estrogens.

    Call: SONATA 19 , Panel: NZ4

    Principal investigator: dr Piotr Szczepaniak

    Uniwersytet Jagielloński, Collegium Medicum

  28. Increasing sensitivity to immunotherapy in lung cancer via immunostimulation and modulation of tumor microenvironment

    Call: SONATA BIS 13 , Panel: NZ5

    Principal investigator: dr Urszula Oleksiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  29. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  30. The mechanism of competition of mutant p53 gain-of-function and major oncogene CMYC in gastric cancer.

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Marcin Mikołaj Grochowski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  31. Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  32. Efficiency biomarkers in photodynamic therapy against lung cancer

    Call: PRELUDIUM 2 , Panel: NZ4

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  33. Investigating the anti-cancerous effect of antioxidant extract from spent coffee grounds on the functioning of normal an...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Adrianna Maria Piasek

    Politechnika Warszawska, Wydział Chemiczny

  34. The study of the effect of hypoxia on the metabolism of exogenous ferritin and its role in the regulation of free iron i...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: dr Małgorzata Maria Kubiak

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Centrum Immunoterapii Komórkowych

  35. Functional consequences of loss of chromosome Y (LOY) in immune cells in the context of cancer - ex vivo and in vitro st...

    Call: OPUS 25 , Panel: NZ2

    Principal investigator: dr Jan Dumański

    Gdański Uniwersytet Medyczny, Międzynarodowa Agenda Badawcza

  36. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Angelika Muchowicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  37. Determining the frequency of occurrence and defining the most appropriate screening test for anal intraepithelial neopla...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Michał Zygmunt Brzeziński

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej, Zakład Propedeutyki Onkologii

  38. Assessing ovarian cancer molecular heterogeneity by NMR-based metabolomics, spatially resolved transcriptomics and metab...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Maria Bożena Sokół

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  39. Ultrasensitive profiling of mutations driving tumorigenesis in hereditary syndromes associated with tumor suppressor gen...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr Katarzyna Klonowska

    Instytut Chemii Bioorganicznej PAN

  40. Investigating the mechanisms of epithelial/mesenchymal plasticity and metastasis.

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr Anna Agnieszka Marusiak

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  41. Spatial Determinants of Immunotherapy Resistance in Cancer

    Call: WEAVE-UNISONO , Panel: NZ6

    Principal investigator: dr Marcin Tabaka

    Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka

  42. Dissecting the regulatory interplay between proteases and protein kinases in acute lymphoblastic leukemia using mass cyt...

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  43. Determination of the SNAIL1 transcription factor effect on biology cancer stem cells in rhabdomyosarcoma model

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: prof. Marcin Marek Majka

    Uniwersytet Jagielloński, Collegium Medicum

  44. Identifying angiogenic and metabolic biomarkers in endometriosis-associated ovarian cancer using photoacoustic imaging a...

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Monika Anna Golińska

    Uniwersytet Medyczny w Łodzi

  45. Development and differentiation of early-stage" myeloid-derived suppressor cells (e-MDSCs) in colorectal cancer – the ro...

    Call: OPUS 24 , Panel: NZ6

    Principal investigator: dr hab. Jarosław Tomasz Baran

    Uniwersytet Jagielloński, Collegium Medicum

  46. Functional analysis of monocyte chemoattractant protein-induced protein (MCPIP) in human neuroblastoma cells

    Call: OPUS 2 , Panel: NZ1

    Principal investigator: prof. Hanna Barbara Rokita

    Uniwersytet Jagielloński

  47. Role of microparticles derived from platelets and cancer cells in colorectal cancer progression – how to stop them or tu...

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: prof. Maria Anna Kowalska

    Instytut Biologii Medycznej PAN

  48. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  49. Extracellular matrix and matrix-processing cells in pathophysiology of pancreatic cancer

    Call: SONATA BIS 12 , Panel: NZ4

    Principal investigator: dr Monika Anna Jakubowska

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  50. Oncogene competition - a new interplay mechanism of mutant p53 with CMYC and mutant KRAS in human cancers.

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Dawid Włodzimierz Walerych

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy